290 related articles for article (PubMed ID: 20554964)
1. IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail.
Ho AW; Shen F; Conti HR; Patel N; Childs EE; Peterson AC; Hernández-Santos N; Kolls JK; Kane LP; Ouyang W; Gaffen SL
J Immunol; 2010 Jul; 185(2):1063-70. PubMed ID: 20554964
[TBL] [Abstract][Full Text] [Related]
2. SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction.
Onishi RM; Park SJ; Hanel W; Ho AW; Maitra A; Gaffen SL
J Biol Chem; 2010 Oct; 285(43):32751-32759. PubMed ID: 20729198
[TBL] [Abstract][Full Text] [Related]
3. A CC' loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation.
Liu C; Swaidani S; Qian W; Kang Z; Sun P; Han Y; Wang C; Gulen MF; Yin W; Zhang C; Fox PL; Aronica M; Hamilton TA; Misra S; Deng J; Li X
Sci Signal; 2011 Nov; 4(197):ra72. PubMed ID: 22045852
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of IL-17 receptor B SEFIR domain.
Zhang B; Liu C; Qian W; Han Y; Li X; Deng J
J Immunol; 2013 Mar; 190(5):2320-6. PubMed ID: 23355738
[TBL] [Abstract][Full Text] [Related]
5. Structural Analysis Reveals that the Cytokine IL-17F Forms a Homodimeric Complex with Receptor IL-17RC to Drive IL-17RA-Independent Signaling.
Goepfert A; Lehmann S; Blank J; Kolbinger F; Rondeau JM
Immunity; 2020 Mar; 52(3):499-512.e5. PubMed ID: 32187518
[TBL] [Abstract][Full Text] [Related]
6. Structure of the unique SEFIR domain from human interleukin 17 receptor A reveals a composite ligand-binding site containing a conserved α-helix for Act1 binding and IL-17 signaling.
Zhang B; Liu C; Qian W; Han Y; Li X; Deng J
Acta Crystallogr D Biol Crystallogr; 2014 May; 70(Pt 5):1476-83. PubMed ID: 24816115
[TBL] [Abstract][Full Text] [Related]
7. IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis.
Hu Y; Ota N; Peng I; Refino CJ; Danilenko DM; Caplazi P; Ouyang W
J Immunol; 2010 Apr; 184(8):4307-16. PubMed ID: 20231694
[TBL] [Abstract][Full Text] [Related]
8. IL-17RC: a partner in IL-17 signaling and beyond.
Ho AW; Gaffen SL
Semin Immunopathol; 2010 Mar; 32(1):33-42. PubMed ID: 20012905
[TBL] [Abstract][Full Text] [Related]
9. Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis.
Whibley N; Tritto E; Traggiai E; Kolbinger F; Moulin P; Brees D; Coleman BM; Mamo AJ; Garg AV; Jaycox JR; Siebenlist U; Kammüller M; Gaffen SL
J Leukoc Biol; 2016 Jun; 99(6):1153-64. PubMed ID: 26729813
[TBL] [Abstract][Full Text] [Related]
10. The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction.
Ho AW; Garg AV; Monin L; Simpson-Abelson MR; Kinner L; Gaffen SL
PLoS One; 2013; 8(7):e70168. PubMed ID: 23922952
[TBL] [Abstract][Full Text] [Related]
11. IL-17A versus IL-17F induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in AGS gastric adenocarcinoma cells.
Zhou Y; Toh ML; Zrioual S; Miossec P
Cytokine; 2007 Jun; 38(3):157-64. PubMed ID: 17644350
[TBL] [Abstract][Full Text] [Related]
12. The IL-17F/IL-17RC Axis Promotes Respiratory Allergy in the Proximal Airways.
De Luca A; Pariano M; Cellini B; Costantini C; Villella VR; Jose SS; Palmieri M; Borghi M; Galosi C; Paolicelli G; Maiuri L; Fric J; Zelante T
Cell Rep; 2017 Aug; 20(7):1667-1680. PubMed ID: 28813677
[TBL] [Abstract][Full Text] [Related]
13. Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis.
Conti HR; Whibley N; Coleman BM; Garg AV; Jaycox JR; Gaffen SL
PLoS One; 2015; 10(4):e0122807. PubMed ID: 25849644
[TBL] [Abstract][Full Text] [Related]
14. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.
Qian Y; Liu C; Hartupee J; Altuntas CZ; Gulen MF; Jane-Wit D; Xiao J; Lu Y; Giltiay N; Liu J; Kordula T; Zhang QW; Vallance B; Swaidani S; Aronica M; Tuohy VK; Hamilton T; Li X
Nat Immunol; 2007 Mar; 8(3):247-56. PubMed ID: 17277779
[TBL] [Abstract][Full Text] [Related]
15. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex.
Wright JF; Bennett F; Li B; Brooks J; Luxenberg DP; Whitters MJ; Tomkinson KN; Fitz LJ; Wolfman NM; Collins M; Dunussi-Joannopoulos K; Chatterjee-Kishore M; Carreno BM
J Immunol; 2008 Aug; 181(4):2799-805. PubMed ID: 18684971
[TBL] [Abstract][Full Text] [Related]
16. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F.
Kuestner RE; Taft DW; Haran A; Brandt CS; Brender T; Lum K; Harder B; Okada S; Ostrander CD; Kreindler JL; Aujla SJ; Reardon B; Moore M; Shea P; Schreckhise R; Bukowski TR; Presnell S; Guerra-Lewis P; Parrish-Novak J; Ellsworth JL; Jaspers S; Lewis KE; Appleby M; Kolls JK; Rixon M; West JW; Gao Z; Levin SD
J Immunol; 2007 Oct; 179(8):5462-73. PubMed ID: 17911633
[TBL] [Abstract][Full Text] [Related]
17. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis.
Boisson B; Wang C; Pedergnana V; Wu L; Cypowyj S; Rybojad M; Belkadi A; Picard C; Abel L; Fieschi C; Puel A; Li X; Casanova JL
Immunity; 2013 Oct; 39(4):676-86. PubMed ID: 24120361
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization and evolution analysis of five interleukin-17 receptor genes in large yellow croaker Larimichthys crocea.
Ding Y; Ai C; Mu Y; Ao J; Chen X
Fish Shellfish Immunol; 2016 Nov; 58():332-339. PubMed ID: 27633682
[TBL] [Abstract][Full Text] [Related]
19. Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
Shi P; Zhu S; Lin Y; Liu Y; Liu Y; Chen Z; Shi Y; Qian Y
Sci Signal; 2011 Nov; 4(197):ra73. PubMed ID: 22045853
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis.
Ferreira MC; Whibley N; Mamo AJ; Siebenlist U; Chan YR; Gaffen SL
Infect Immun; 2014 Mar; 82(3):1030-5. PubMed ID: 24343647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
